Immix Biopharma, Inc. (IMMX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 172.41M |
| Enterprise Value | 79.56M |
| P/E Ratio | -13.86 |
| PEG Ratio | 1.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.4 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.17 |
| Return On Equity | -0.38 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -29.59M |
| Net Income | -29.44M |
| Diluted EPS | -0.89 |
| Total Cash | 232.11M |
| Total Cash/Share | 3.64 |
| Total Debt | 1M |
| Total Debt/Equity | 0 |
| Current Ratio | 25.13 |
| Book Value Per Share | 3.59 |
| 52-Week Change | 449.32 |
| 52-Week High | 15.1 |
| 52-Week Low | 1.94 |
| Moving Average 50 Days | 11.17 |
| Moving Average 200 Days | 8.64 |
| Average Volume | 1.85M |
| Shares Outstanding | 54.4M |
| % Held by Institutions | 88.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |